TECHNOLOGIES

Technologies

High Quality Powder Coating Process Using Ultrafine Powders

Improved fluidization, handling and spraying of ultrafine paint powders enable smooth, thin dry coatings. Control of interparticle interactions and powder formulation supports high-quality surface finishing and adaptation of existing powder coating equipment.

Technical problem

Electrostatic powder coating avoids liquid solvents and allows overspray to be recovered. Conventional paint powders are generally larger than 30 μm, with a typical range of 30–50 μm. These relatively coarse powders limit surface smoothness. Ultrafine powders around 10–15 μm can improve the finish, but stronger interparticle interactions make uniform fluidization and spraying difficult.

Principles and innovation

The technology modifies the interactions between ultrafine paint particles to improve powder flow and fluidization, enabling more uniform delivery and spraying. Changes to the paint formulation further improve fluidity and reduce the orange-peel texture of the finished coating.

These methods produced dry powder finishes comparable to liquid-painted surfaces and thinner coatings than those obtained with coarse powders. Solvent avoidance, overspray recovery and reduced coating thickness contribute to the material-use and environmental benefits.

Applications and equipment adaptation

Applications include automotive exterior surfaces and other products requiring a smooth finish. Existing electrostatic coating lines for coarse powders can be adapted to finer powders through equipment modifications.

Validation and applications

The technology was applied at Liffey Custom Coatings Inc. in Ontario to replace coarse powders with ultrafine powders. It was subsequently applied at Fine Shine Inc. in Shanghai and introduced to other industrial users.

The technology is associated with five patents.

Pulmonary Drug Delivery

Fluidization-based microdosing and dry powder inhalers address the agglomeration, metering and delivery of drug particles smaller than 5 μm. The technology combines precise powder dispensing with dispersion and transport during inhalation.

Technical problem

Pulmonary delivery carries an inhaled drug to the lungs, reducing exposure to gastrointestinal degradation and first-pass metabolism and offering a route for some peptides that are unsuitable for oral delivery. The technology addresses drug particles smaller than 5 μm and very small doses. Agglomeration, accurate metering and dispersion during inhalation are therefore closely connected challenges.

When coarse carrier particles or liquid media are used to handle fine drug powders, separation of the drug from its carrier or droplets affects the delivered quantity. This work focuses on handling minute quantities of ultrafine dry powder and controlling transport from dispensing to inhalation.

Principles and devices

The dispensing device uses a rotating fluidized bed. Airflow first suspends the fine drug powder uniformly. Controlled particle discharge then meters the powder into single-dose containers such as blisters, enabling direct handling of these small quantities.

The complementary dry powder inhaler is driven by the patient’s breath to disperse the metered powder and deliver it towards the lungs. The dispensing device and inhaler form the two parts of the technology.

Parameters and performance

  • Drug particle sizes of 1–5 μm.
  • Two microdosing ranges of 50–500 μg and 0.05–1.0 mg (50–1000 μg).
  • Powder delivery efficiency approaching 80% for the developed inhaler.

Applications and development

Applications include insulin and other ultrafine drug powders requiring accurate dose control. Development involved collaboration with pharmaceutical companies, preclinical preparations and applications for regulatory approval. The work is associated with four patents.

Circulating Fluidized Bed Biological Reactor for Efficient Wastewater Treatment Process

A circulating fluidized bed combines fixed-film treatment with biological nutrient removal. Distinct reaction environments and continuous particle circulation support removal of organic carbon, nitrogen and phosphorus in compact municipal and industrial wastewater systems.

Technical problem

Wastewater treatment must meet requirements for organic matter, nitrogen and phosphorus removal within constraints on plant capacity and available space. This technology combines an attached biofilm with biological nutrient removal (BNR). Fluidization provides extensive contact, rapid mass transfer and high biomass density to increase treatment intensity per unit reactor volume.

Reactor and circulation principles

The liquid–solid circulating fluidized bed bioreactor (LSCFBBR) consists of interconnected riser and downer beds. Liquid carries support particles upwards in the riser. After separation at the top, the particles enter the downer, where they descend against upward liquid flow before returning to the riser through a bottom connection. Flow regulation maintains the solids circulation balance. Gas can also be introduced to create a gas–liquid–solid system.

The beds maintain different reaction environments while continuously exchanging particles carrying attached microorganisms. Air supplied to the downer creates an aerobic zone. The lower and upper parts of the riser provide anoxic and anaerobic zones. Incoming wastewater, circulating carriers and some recycled nitrified liquid meet in the riser. Anoxic denitrification and anaerobic phosphorus release are followed by organic matter removal, nitrification and phosphorus uptake in the aerobic zone. Liquid and solids recirculation link these processes for combined carbon, nitrogen and phosphorus removal.

Process features and applications

Attached growth improves biomass retention, while the settling behaviour of carrier particles allows more compact separation equipment. The process reduces reliance on conventional primary and secondary clarification and handles wastewater containing both dissolved pollutants and suspended particulate matter.

Other process features include resistance to organic loading shocks, operational stability, lower sludge production and reduced requirements for chemical phosphorus removal, oxygen and added carbon. Detached biofilm can supply part of the carbon required for denitrification. Treatment performance depends on the biofilm, influent composition and operating conditions.

Applications include municipal wastewater, decentralized treatment and reuse for residential developments or small buildings, and industrial effluents such as those from meat processing. Compact equipment is particularly relevant where space is limited or reduced dependence on municipal treatment is sought.

Validation and demonstrations

In a wastewater-treatment-plant pilot, hydraulic retention time decreased from 24 h to 2 h and sludge production fell by approximately two-thirds.

Demonstrations in London, Canada, between 2007 and 2014 included a 5 t/d pilot and a 50 t/d mobile system, with support from Trojan Technology, the City of London, Ontario Centre of Excellence and NSERC. A Chinese company also pursued commercialization through technology licensing and completed a 2000 t/d demonstration unit.

Direct Dry Powder Coating for Pharmaceutical Solid Dosage Forms

Dry powder is applied directly to solid dosage forms and fused into a coating, reducing solvent evaporation and hot-air handling. The process and equipment adaptations cover tablets, pellets and beads with a range of functional coatings.

Technical problem

Coatings improve the stability of solid dosage forms, mask unpleasant tastes or odours, control release and separate incompatible components. Conventional wet processes apply an aqueous or organic-solvent coating liquid and dry it into a film. This requires solvent evaporation, heated air and exhaust treatment. Small particles can also stick together when wet, often requiring fluidized bed equipment with substantial air consumption.

Principles and innovation

Electrostatic direct dry powder coating applies powder to dosage forms in a coating pan, followed by fusion and solidification into a uniform, dense layer of adjustable thickness. Water or organic solvent is not used as the coating medium, reducing the energy, time and exhaust handling associated with solvent evaporation. When replacing organic-solvent coating, the process also avoids emissions from that solvent source.

The technology includes both the coating process and equipment adaptations. Existing wet coating pans can be converted with minor modifications. The pan-based approach can also accommodate smaller solid dosage forms, reducing reliance on the fluidized bed equipment used for wet coating of small particles.

Functions and applications

The process has been adapted to a range of commercial pharmaceutical coating materials, including immediate-release, enteric, sustained-release and osmotic-pump coatings. Applications include tablets, pellets, beads, capsules, confectionery and other solid substrates requiring a coating.

Process performance

The process produces surface density and gloss comparable to wet coating. Performance figures from process development include the following.

  • Coating-material utilization above 80%.
  • Total processing time below 1 h.
  • Compressed-gas consumption of 0.67–3 m³/kg of solid dosage forms.

Comparisons with liquid coating showed approximately 70% lower energy use and 90% less hot-air handling. Performance varies with the coating formulation, equipment scale and operating conditions.

Scale-up and commercialization

The technology is associated with eleven patents. Scale-up was completed with a pharmaceutical equipment company, and two spin-off companies were established to advance commercialization.

High-efficiency Ultrafine Particle Group C-Plus Fluidized Bed Reactor

Control of cohesive interactions improves Group C powder fluidization, while nano-modulation produces Group C+ particles. The approach combines high specific surface area, bed expansion and gas holdup to improve contact and reaction performance in gas–solid catalysis.

Technical problem

Ultrafine Geldart Group C powders exhibit strong interparticle forces, agglomerate readily and are difficult to fluidize or handle reliably. Their high specific surface area is attractive for contact and reaction, but conventional fluidization does not readily exploit this advantage.

Assisted fluidization and nano-modulation

Weakening interparticle interactions improves the flow and fluidization of fine powders. Development has produced several patented and patent-pending assisted-fluidization methods. Thorough mixing and dispersion of nanoparticles within Group C powders modify their flow and fluidization behaviour to form Group C+ particle systems.

This approach is termed nano-modulation. The resulting Group C+ particles retain the high specific surface area of ultrafine powders while exhibiting substantial bed expansion and increased dense-phase gas holdup. Greater gas–solid interfacial area and longer gas residence time help improve contact efficiency.

Reaction validation

In model-reaction tests, conversion in a Group C+ catalytic fluidized bed reactor reached up to 2.35 times that of the Group A particle reference system, with higher gas–solid contact efficiency.

Reaction performance depends on particle properties, the reaction system and reactor operating conditions.

Applications and related technologies

Applications include stable handling of cohesive ultrafine powders and gas-phase catalytic reactions. The platform also supports powder flow and dispersion in ultrafine powder coating and pulmonary drug delivery.

Liquid-Solid Circulating Fluidized Bed for Bio-Processes and Separations

Interconnected liquid–solid fluidized beds allow adsorption and desorption or regeneration to proceed continuously in separate columns. Circulating ion-exchange particles support separation from dilute, high-volume streams, including feeds containing suspended contaminants.

Technical problem

Chemical, biochemical, environmental, pharmaceutical and food processes often require recovery of selected chemicals, ions or proteins from multicomponent liquids. Dilute, high-volume feeds containing suspended contaminants are particularly challenging, and those contaminants can obstruct fixed beds. Single-stage fluidized beds alleviate particle blockage but do not readily link adsorption and regeneration into a continuous system.

Principles and innovation

Interconnected liquid–solid fluidized bed columns conduct adsorption and desorption or regeneration separately and simultaneously. Ion-exchange particles circulate between the columns, connecting target capture with restoration of the exchange medium in continuous operation.

Spaces between the fluidized particles allow small suspended contaminants and some unwanted components to pass with the liquid, enabling direct treatment of certain impure streams. The system combines selectivity, dynamic capacity and throughput for large volumes of dilute feed. Performance depends on the exchange medium and the particular separation system.

Applications and commercialization

In protein recovery from cheese-production effluent, protein adsorption and ion-exchange resin regeneration can proceed continuously in two connected columns.

The technology was licensed to Renix in London, Canada, and commercialized as CFIX continuous fluidized bed ion exchange for applications in food, beverages and mining.

Fluidized Bed Wear Tester for Dental and Other Materials

Specimens are exposed to slowly moving particles to study prolonged wear under low loads. Adjustable particles, motion and liquid environments support testing of dental restorative materials and potential applications to metallic and non-metallic materials.

Testing problem

Dental restorative materials experience wear over long periods in the mouth. Conventional pin-on-disc tests often apply relatively high loads for short durations, making them a poor representation of prolonged low-load service. In vivo clinical testing typically requires 6–12 months to obtain reliable data and is affected by differences between participants’ oral environments. Toothpaste and toothbrush abrasion tests also have limitations in reproducing the environment and evaluating long-term behaviour.

Instrument principles and adjustable conditions

The fluidized bed wear tester places specimens among slowly moving particles, exposing them to sustained abrasion and collisions. Particle material, properties and movement frequency can be selected, and loading conditions adjusted, to study wear resistance over longer periods at lower loads.

Control of the particles and operating conditions allows approximations of different oral wear environments. Introducing liquids with different properties also creates combined wear and corrosion conditions for studying environmental effects on material durability.

Validation and applications

The instrument has been used to test several dental materials. Potential applications extend to long-term wear evaluation of metallic and non-metallic materials and to studies of combined wear and corrosion.